Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.3
28.67%
40%
—
12x
80%
—
5 Years
Score5.3
Net Growth28.67%
Net Trend40%
Net Income Consistency—
Rev Growth12x
Rev Trend80%
Revenue Consistency—
Nanobiotix fundamental performance
Between 2020 and 2025, revenue grew from € 2M to € 29M and net income went from -€ 33M to -€ 23M. Revenue increased in 4 of those 5 years; net income in 2.
Nanobiotix currently holds a 5-year HDB Score of 5.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 39.44 | — |
1 Year2025-08-12 | $ 7.40 | 432.97% |
5 Years2021-08-12 | $ 12.90 | 205.74% |
All Time2020-12-11 | $ 16.98 | 132.27% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-12-11 |
|---|---|---|---|---|
| Price | $ 39.44 | $ 7.40 | $ 12.90 | $ 16.98 |
| Return | — | 432.97% | 205.74% | 132.27% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | € 29M | -€ 23M | € 52M |
| 2024 | -€ 7M | -€ 68M | € 49M |
| 2023 | € 36M | -€ 39M | € 75M |
| 2022 | € 4M | -€ 57M | € 41M |
| 2021 | € 2M | -€ 47M | € 84M |
| IPO2020 | € 2M | -€ 33M | € 119M |
Explore beyond NBTX
You're looking at Nanobiotix. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
